Members across leading European institutions in breast cancer research

This research brings together prominent academic and clinical institutions from across Europe, including the Netherlands Cancer Institute (coordinating center), Institut Curie, Institut Paoli-Calmettes, Lund University, Masaryk Memorial Cancer Institute, Medical University Vienna, Pomeranian Medical University, Rigshospitalet, Universitätsklinikum Köln, University of Cambridge, and the University of Southern Denmark.

International expertise from across Europe

With collaboration from researchers in Austria, the Czech Republic, Denmark, France, Germany, the Netherlands, Poland, Spain, Sweden, and Hungary, IBCCS covers a broad spectrum of research on BRCA1/2 carriers. This collaboration strengthens research and underscores the importance of sharing resources and knowledge to address the complex challenges associated with hereditary cancer risks.